Searchable abstracts of presentations at key conferences in endocrinology

ea0095p149 | Pituitary and Growth 2 | BSPED2023

Standard clinical diagnostic criteria for Silver–Russell Syndrome frequently overlooks monogenic causes

Palau Helena , Kurup Uttara , Ishida Miho , Maharaj Avinaash V , Davies Justin H. , Storr Helen L.

Background: A diagnosis Silver–Russell Syndrome (SRS) is important for early institution of appropriate management, access to therapy and reduces the burden of diagnostic uncertainty. SRS is molecularly heterogeneous and 11p15 LOM/upd(7)mat account for ~60% cases. Monogenic causes include variants in HMGA2, CDKN1C, IGF-2, PLAG1 and contribute to 5% cases. Clinical SRS diagnosis requires the fulfilment of ≥4/6 Netchine–Harbison Clinical Scoring ...

ea0039ep8 | Adrenal | BSPED2015

Intravenous Etomidate in the management of hypercortisolaemia due to ectopic ACTH producing thymic neuroendocrine tumor

Arya Ved Bhushan , Irvine Vanessa , Rowlands Helen , Sykes Kim , Nicolin Gary , Drake William , Storr Helen , Davies Justin H

Background: Ectopic-ACTH syndrome (EAS) is an extremely rare cause of Cushing’s syndrome in young children. The intensity of ACTH secretion and hypercortisolaemia is greater in EAS than in Cushing’s disease. Control of hypercortisolaemia represents a key management step while awaiting localization of the ACTH source or in preparation to surgery. Etomidate inhibits cortisol synthesis and its rapid onset of action makes it an ideal medication in severe hypercortisolaem...

ea0078OC6.2 | Oral Communications 6 | BSPED2021

Body composition in adults with genetically-confirmed Silver-Russell syndrome.

Lokulo-Sodipe Oluwakemi , Inskip Hazel. M. , Byrne Christopher D. , Child Jenny , Wakeling Emma L. , Mackay Deborah J.G. , Temple I. Karen , Davies Justin H.

Silver-Russell syndrome (SRS) is characterised by low birth weight, short stature, and feeding difficulties in childhood, with marked leanness also described. There is limited information on body composition in older people with SRS.Objective: To evaluate body composition in adults with SRS. Methods: Participants aged ≥18 years with molecularly-confirmed SRS attended a single study appointment. Body composition was evaluated ...

ea0039oc7.6 | Oral Communications 7 | BSPED2015

The evolving phenotype of transient neonatal diabetes 1: findings from the international register

Lokulo-Sodipe Kemi , James Rowena S , Zalkapli N N , Docherty Louise E , Davies Justin H , Mackay Deborah J G , Temple I Karen

Introduction: Transient neonatal diabetes 1 (TNDM1) has an estimated incidence of 1 in 400 000 and is characterised by intra-uterine growth retardation and diabetes presenting soon after birth. Spontaneous remission of diabetes usually occurs within the first year of life. TNDM1 is caused by overexpression of imprinted genes at chromosome 6q24. Three causes have been described: paternal uniparental disomy for chromosome 6; paternally inherited duplication of 6q24; and maternal...

ea0058p025 | Growth | BSPED2018

The phenotype and cardio-metabolic associations of Silver-Russell syndrome in an older cohort and the effects of childhood growth hormone treatment

Lokulo-Sodipe Oluwakemi , Wakeling Emma L , Child Jenny , Mackay Deborah JG , Inskip Hazel M , Byrne Christopher D , Davies Justin H , Karen Temple I

The classical features of Silver-Russell syndrome (SRS) appear to become less pronounced with increasing age. Small-for-gestational-age (SGA) birth is associated with adult metabolic syndrome. SRS is associated with SGA but the adult sequelae and long-term effects of childhood growth hormone (GH) treatment are unclear.Objective: To determine the phenotype and cardio-metabolic profile in older individuals with SRS and compare individuals previously untrea...

ea0033oc5.3 | Oral Communications 5 | BSPED2013

Hypoglycaemia success during the insulin tolerance test: a two centre comparison

Besser Rachel , Chen Suet Ching , Knight Emma , McNeil Ethel , Musson Pauline , Fisher Victoria , Kerr Stephanie , Donaldson Malcolm , Davis Nikki , Ahmed Faisal , Shaikh M Guftar , Davies Justin

Introduction: The insulin tolerance test (ITT) is the gold standard method to assess GH and/or ACTH deficiency. Safety concerns with the use of this test were raised more than 20 years ago from overtreatment of hypoglycaemia and consequent cerebral oedema, resulting in some centres using alternative tests. We have re-appraised use of the ITT in a contemporary setting and evaluated: i) timing of the glucose nadir, ii) time to resolution of hypoglycaemia, iii) adverse events and...

ea0030oc2.6 | Oral Communications 2 | BSPED2012

Childhood body composition is associated with maternal plasma polyunsaturated fatty acids status in late pregnancy

Moon Rebecca J , Harvey Nicholas C , Ntani Georgia , Davies Justin H , Inskip Hazel M , Godfrey Keith , Dennison Elaine M , Calder Philip , Cooper Cyrus

Introduction: Maternal diet during pregnancy has been linked to offspring body composition, but the specific nutrients and mechanisms involved are not well understood. Higher n-3 polyunsaturated fatty acid (PUFA) status is associated with lower risk of adiposity in adults, whereas n-6 PUFA are adipogenic. The effect of maternal PUFA in determining offspring body composition is unknown.Method: We evaluated the relationships between maternal ...

ea0077oc6.1 | Thyroid | SFEBES2021

Adjuvant Rituximab – exploratory trial in young people with Graves’ disease

Cheetham Tim , Cole Michael , Abinun Mario , Alalhabadia Amit , Barratt Tim , Davies Justin , Dimitri Paul , Drake Amanda , Mohamed Zainaba , Murray Robert , Steele Caroline , Zammitt Nicola , Carnell Sonya , Prichard Jonathan , Watson Gillian , Hambleton Sophie , Matthews John , Pearce Simon

Objective: Remission rates in young people with Graves’ hyperthyroidism are <25% after a 2-yr course of thionamide antithyroid drug (ATD). Immunomodulatory agents might improve outcome by facilitating immune tolerance. We explored whether rituximab (RTX) would increase remission rates when administered with a short course of ATD.Design: This was an open label multi-centre single arm phase 2 trial in newly presenting young people (12-20y) with Gr...

ea0078oc4.7 | Oral Communications 4 | BSPED2021

The use of urinary steroid profiles in monitoring therapy in children with 21-hydroxylase deficiency – results from the CAH-UK cohort study

Bacila Irina , Lawrence Neil , Alvi Sabah , Cheetham Timothy , Crowne Elizabeth , Das Urmi , Dattani Mehul , Davies Justin H , Gevers Evelien , Krone Ruth , Kyriakou Andreas , Patel Leena , Randell Tabitha , Ryan Fiona , S Faisal Ahmed , Keevil Brian , Taylor Norman , Krone Nils

Introduction: Monitoring glucocorticoid (GC) replacement in patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) remains challenging. There are disease-specific patterns in the plasma and urinary steroid profiles in 21OHD, a key role being played by the 11-oxygenatedC19 androgens. Aim: To explore the urinary steroid profile in 21OHD in relation to treatment and plasma steroids. Methods: Partic...

ea0085p1 | Adrenal 1 | BSPED2022

Recommendations for hydrocortisone doses for emergency management and peri-operative care for childhood adrenal insufficiency. BSPED consensus guidelines

Mushtaq Talat , Ali Salma , Boulos Nabil , Boyle Roisin , Cheetham Tim , Davies Justin , Elder Charlotte , Gan Hoong-Wei , Hindmarsh Peter , Katugampola Harshini , Kerr Stephanie , Krone Nils , Salomon Estebanez Maria , Shenoy Savitha , Tollerfield Sally , Choong Wong Sze , Regan Fiona

Adrenal insufficiency (AI) is characterised by lack of cortisol production from the adrenal glands which is treated with replacement doses of hydrocortisone. At times of physiological stress there is an increased requirement for exogenous glucocorticoids, which if untreated can lead to an adrenal crisis. Currently there are no unified guidelines for those <18 years old in the UK; this can lead to a substantial variation in the management of AI in both an emergency and peri...